# Leflunomide

## Arheuma 10mg

##### 

| Title              | Content                                                                                                                                                                                                                                                                        |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OARH1                                                                                                                                                                                                                                                                          |
| Indications        | Treatment of RA & psoriatic arthritis in adult.                                                                                                                                                                                                                                |
| Dosing             | Adult loading dose 100 mg once daily for 3 days. Maintenance dose rheumatoid arthritis 10-20 mg once daily， psoriatic arthritis 20 mg once daily.                                                                                                                             |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                       |
| Contraindications  | Stevens-Johnson syndrome， toxic epidermal necrolysis， multiforme epithelium. Hepatic dysfunction， severe immunodeficiency such as AIDS， bone-marrow dysplasia， severe infections， moderate to severe renal dysfunction， severe hypoproteinaemia. Pregnancy， lactation. |
| Adverse Effects    | Increase in BP; GI disturbances， anorexia， oral mucosal disorders， weight loss; headache， dizziness， asthenia， paraesthesia; tenosynovitis; alopecia， eczema， dry skin， rash， pruritus; hypersensitivity reactions， leucopenia.                                     |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                   |

